People don’t come to work every day to make money for shareholders, observes Vir Biotechnology president and CEO George Scangos. In biotech, he finds, most teams are instead motivated by the prospect of improving peoples’ lives. Consequently, he argues, his role as CEO is not to focus exclusively on maximizing shareholder returns, but to also think about responsibilities to other stakeholders, including patients, employees, the community and the environment.

Video clips from: Making a Difference in Biotech [Entire Talk]

7 minutes

Going All-In on Infectious Diseases

Watch now

4 minutes

Preparing the Market

Watch now

3 minutes

Urgency and Purpose

Watch now

4 minutes

The Accelerating Pace of Biotech Innovation

Watch now

2 minutes

The Evolution of Biotech

Watch now

Share Post